| Date Checked | 2025-12-21 23:22:23 |
|---|---|
| Graham Number | (PB)nan vs (PE)135.85 |
| Over / Under Value Percentage | 0.00% vs nan% |
| Dividend Yield | 0.36% |
| Dividend Date | 2026-01-02 |
| Symbol | MCK |
| AssetType | Common Stock |
| Name | McKesson Corporation |
| Description | McKesson Corporation (MCK) is a pivotal leader in the U.S. healthcare industry, specializing in the distribution of pharmaceuticals and medical supplies, as well as providing comprehensive healthcare management solutions. Leveraging advanced technology and a broad service portfolio, McKesson enhances operational efficiencies for a diverse range of healthcare stakeholders, including providers, payers, and pharmaceutical partners. The company’s focus on innovation not only strengthens its competitive edge but also improves patient outcomes and optimizes healthcare delivery. As a key participant in the evolving healthcare landscape, McKesson is committed to fostering a more efficient and patient-centered approach to healthcare service. |
| CIK | 927653 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | MEDICAL DISTRIBUTION |
| Address | 6555 STATE HIGHWAY 161, IRVING, TX, UNITED STATES, 75039 |
| OfficialSite | https://www.mckesson.com |
| FiscalYearEnd | March |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 102026297000 |
| EBITDA | 6507000000 |
| PERatio | 25.64 |
| PEGRatio | 0.979 |
| BookValue | -14.02 |
| DividendPerShare | 2.95 |
| EPS | 31.99 |
| RevenuePerShareTTM | 3096.75 |
| ProfitMargin | 0.0104 |
| OperatingMarginTTM | 0.0137 |
| ReturnOnAssetsTTM | 0.0478 |
| ReturnOnEquityTTM | 0 |
| RevenueTTM | 387093987000 |
| GrossProfitTTM | 13324000000 |
| DilutedEPSTTM | 31.99 |
| QuarterlyEarningsGrowthYOY | 3.77 |
| QuarterlyRevenueGrowthYOY | 0.101 |
| AnalystTargetPrice | 939.33 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 10 |
| AnalystRatingHold | 3 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | 25.64 |
| ForwardPE | 18.52 |
| PriceToSalesRatioTTM | 0.264 |
| PriceToBookRatio | 5.04 |
| EVToRevenue | 0.273 |
| EVToEBITDA | 17.43 |
| Beta | 0.383 |
| 52WeekHigh | 894.75 |
| 52WeekLow | 563.37 |
| 50DayMovingAverage | 822.45 |
| 200DayMovingAverage | 731.46 |
| SharesOutstanding | 123427000 |
| SharesFloat | 123258000 |
| PercentInsiders | 0.029 |
| PercentInstitutions | 90.818 |
| ExDividendDate | 2025-12-01 |
| dateChecked | 2025-12-21 23:22:23 |
| fresh | 1 |